摘要
目的探讨噻托溴铵治疗慢性阻塞性肺疾病患者的临床疗效。方法对2010年1月～2012年12月我院治疗的90例慢性阻塞性肺疾病老年患者进行随访,比较患者治疗前及治疗3个月后肺功能、治疗前后3个月内因病情加重入院治疗的次数,同时观察不良反应。结果吸人噻托溴铵后肺功能明显好转,急性加重发作的次数减少,无严重不良反应发生,差异均有统计学意义(P<0.05)。结论噻托溴铵吸入治疗COPD,能明显改善肺功能,减少急性加重发作的次数,是治疗COPD老年患者的有效选择。
Objective： To observe the effects of Tiotropium Bromide Powder in treatment of patients with chronic obstructive pulmonary disease. Methods： There were 90 cases of COPD older patients who received inhaling of tiotropium 18 p.g every day. Their pulmonary function were compared before treatment and three months after the treatment. The number of admissions three months before treatment and three months after treatment was recorded, and the adverse reaction observed. Results： Tiotropium pulmonary function was improved significantly, the number of acute exacerbation of seizures became less, no serious adverse reaction occurred. The differences？ were statistically significant（ P 〈 0.05 ）. Conclusion： Tiotrepium can improve the COPD patient＇ s lung function and alleviate the clinical symptoms obviously. It is an effective choice for treatment of older patients with COPD.
出处
《泰山医学院学报》
CAS
2013年第3期177-178,共2页
Journal of Taishan Medical College
关键词
噻托溴铵
慢性阻塞性肺疾病
肺功能
tiotropium
chronic obstructive pulmonary disease
lung function
